# Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days

> **NCT03363997** · PHASE1 · COMPLETED · sponsor: **Galeno Desenvolvimento de Pesquisas Clínicas** · enrollment: 31 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Estriol 0.125 mg/day
- **DRUG:** Estriol 0.250 mg/day
- **DRUG:** Estriol 0.500 mg/day

## Key facts

- **NCT ID:** NCT03363997
- **Lead sponsor:** Galeno Desenvolvimento de Pesquisas Clínicas
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-23
- **Primary completion:** 2016-12-15
- **Final completion:** 2017-06-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363997, "Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03363997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*